Achondrogenesis is an extremely rare genetic disorder characterized by abnormal bone development. It is estimated to affect approximately 1 in 40,000 to 60,000 births worldwide. This condition is divided into two types: type 1 and type 2. Both types have severe skeletal abnormalities and result in stillbirth or death shortly after birth. Achondrogenesis is caused by mutations in specific genes that are involved in bone formation. Due to its rarity and severity, it is crucial for affected individuals and their families to receive comprehensive medical and genetic counseling.
Achondrogenesis is an extremely rare genetic disorder characterized by abnormal bone development, resulting in severe dwarfism and skeletal abnormalities. It is divided into two subtypes: Achondrogenesis type 1A and Achondrogenesis type 1B.
Achondrogenesis type 1A is the more severe form, with affected individuals typically dying before or shortly after birth. It is estimated to occur in approximately 1 in every 40,000 to 60,000 births.
Achondrogenesis type 1B is a milder form, with affected individuals having a longer lifespan. However, it is still a rare condition, and the exact prevalence is not well-established.
Due to the rarity of Achondrogenesis, it is challenging to determine its exact prevalence. However, it is generally considered to be an extremely rare disorder.